ADMA Biologics, Inc. (ADMA)
13.24
+0.05
(+0.38%)
USD |
NASDAQ |
Nov 12, 16:00
13.45
+0.21
(+1.59%)
After-Hours: 20:00
ADMA Biologics Price to Book Value : 6.727 for Nov. 12, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 6.727 |
| November 11, 2026 | 6.702 |
| November 10, 2026 | 6.437 |
| November 09, 2026 | 6.498 |
| November 06, 2026 | 6.468 |
| November 05, 2026 | 6.712 |
| November 04, 2026 | 5.325 |
| November 03, 2026 | 5.645 |
| November 02, 2026 | 5.619 |
| October 30, 2026 | 5.797 |
| October 29, 2026 | 5.970 |
| October 28, 2026 | 5.731 |
| October 27, 2026 | 5.675 |
| October 26, 2026 | 5.622 |
| October 23, 2026 | 5.426 |
| October 22, 2026 | 5.563 |
| October 21, 2026 | 5.594 |
| October 20, 2026 | 5.706 |
| October 19, 2026 | 5.624 |
| October 16, 2026 | 5.426 |
| October 15, 2026 | 5.452 |
| October 14, 2026 | 5.254 |
| October 13, 2026 | 5.238 |
| October 12, 2026 | 5.172 |
| October 09, 2026 | 5.264 |
| Date | Value |
|---|---|
| October 08, 2026 | 5.248 |
| October 07, 2026 | 5.152 |
| October 06, 2026 | 5.172 |
| October 05, 2026 | 5.137 |
| October 02, 2026 | 4.938 |
| October 01, 2026 | 5.045 |
| September 30, 2026 | 5.096 |
| September 29, 2026 | 5.498 |
| September 28, 2026 | 5.587 |
| September 25, 2026 | 5.178 |
| September 24, 2026 | 5.256 |
| September 23, 2026 | 5.355 |
| September 22, 2026 | 5.416 |
| September 21, 2026 | 5.247 |
| September 18, 2026 | 5.029 |
| September 17, 2026 | 4.941 |
| September 16, 2026 | 4.913 |
| September 15, 2026 | 4.753 |
| September 14, 2026 | 5.046 |
| September 11, 2026 | 5.096 |
| September 10, 2026 | 5.184 |
| September 09, 2026 | 5.217 |
| September 08, 2026 | 5.267 |
| September 04, 2026 | 5.311 |
| September 03, 2026 | 5.289 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.259 |
| BioMarin Pharmaceutical, Inc. | 1.755 |
| Nektar Therapeutics | 1.408 |
| Rhythm Pharmaceuticals, Inc. | 86.57 |
| Arcutis Biotherapeutics, Inc. | 14.22 |
Price to Book Value Related Metrics
| PE Ratio | 17.05 |
| PS Ratio | 5.993 |
| Price to Free Cash Flow | 23.46 |
| Price | 13.24 |
| Earnings Yield | 5.86% |
| Market Cap | 2.950B |
| Operating PE Ratio | 13.34 |
| Normalized PE Ratio | 17.05 |